What is Alkermes plc Quarterly Revenue?

Alkermes plc Quarterly Revenue Alkermes plc Dec-2024 Quarterly Revenue is $430 Million which is growth of 13.9% YoY.

What is Alkermes plc Quarterly Net Profit?

Alkermes plc Quarterly Net Profit Alkermes plc Dec-2024 Quarterly Net Profit is $147 Million which is growth of 29.9% YoY.

What is Alkermes plc Annual Revenue?

Alkermes plc Annual Revenue Alkermes plc Dec-2024 Annual Revenue is $1,558 Million which is growth of -6.4% YoY.

What is Alkermes plc Annual Net Profit?

Alkermes plc Annual Net Profit Alkermes plc Dec-2024 Annual Net Profit is $367 Million which is growth of 3.2% YoY.

What is Alkermes plc Total Shareholders Fund?

Alkermes plc Total Shareholders Fund Alkermes plc Dec-2024 Total Shareholders Fund is $1,465 Million which is growth of 21.8% YoY.

What is Alkermes plc Total Assets?

Alkermes plc Total Assets Alkermes plc Dec-2024 Total Assets is $2,056 Million which is growth of -3.8% YoY.

What is Alkermes plc Book Value Per Share?

Alkermes plc Book Value Per Share Alkermes plc Book Value Per Share is $9 which is growth of 9.5% YoY.

What is Alkermes plc ROE?

Alkermes plc ROE Alkermes plc ROE is 28% which is growth of 4.2% YoY.

What is Alkermes plc Cash From Operating Activity?

Alkermes plc Cash From Operating Activity Alkermes plc Dec-2024 Cash From Operating Activity is $439 Million which is growth of 9.4% YoY.

What is Alkermes plc Net Cash Flow?

Alkermes plc Net Cash Flow Alkermes plc Dec-2024 Net Cash Flow is $-166 Million which is growth of -200.8% YoY.

What is Alkermes plc Annual Revenue?

Alkermes plc Annual Revenue fell 6.36%, in the last year to $1,557.63 M. Its sector's average revenue growth for the last fiscal year was 7.54%.

What is Alkermes plc Annual Net Profit?

Alkermes plc Annual Net Profit rose 3.18% in the last year to $367.07 M. Its sector's average net profit growth for the last fiscal year was -30.36%.

What is Alkermes plc Price to Earning Ratio?

Alkermes plc Price to Earning Ratio is 12.12, higher than its sector PE ratio of 3.22.

What is Alkermes plc Stock Price?

Alkermes plc Stock Price rose 13.21% and outperformed its sector by 5.88% in the past year.

What is Alkermes plc Quarterly Revenue?

Alkermes plc Quarterly Revenue rose 13.91% YoY to $429.99 M. Its sector's average revenue growth YoY for the quarter was 5.84%.

What is Alkermes plc Quarterly Net profit?

Alkermes plc Quarterly Net profit rose 29.9% YoY to $146.5 M. Its sector's average net profit growth YoY for the quarter was -48.37%.

What is Alkermes plc Debt to Equity Ratio?

Alkermes plc Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Alkermes plc Return on Equity(ROE)?

Alkermes plc Return on Equity(ROE) for the last financial year was 27.52%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

What is Alkermes plc Mutual Fund Holding?

Alkermes plc Mutual Fund Holding increased by 0.82% in the last quarter to 83.91.

What is Alkermes plc Promoter Share Holding?

Alkermes plc Promoter Share Holding increased by 0.19% in the most recent quarter to 1.46%.

What is Alkermes plc Interest Coverage Ratio?

Alkermes plc Interest Coverage Ratio is 20.65, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Alkermes plc Institutional Holding?

Alkermes plc Institutional Holding increased by 0.12% in the last quarter to 104.99.

How is the Alkermes plc today?

The Alkermes plc today is trading in the down by -0.74% at 27.00.

How has Alkermes plc performed historically?

The Alkermes plc is currently trading down -0.74% on an intraday basis in the past week the index fell 0.00%. The index has been down -8.38% in the past quarter and rose 13.21% in the past year. You can view this in the overview section.

Alkermes plc XNAS: ALKS

Alkermes plc Live Share Price Today, Share Analysis and Chart

Name: Alkermes plc: Is Infosys Ltd. worth buying?
Item: Alkermes plc
Rating: 2.80341675
Author: Trendlyne DVM scores

Mid-range Performer

Download real time

27.00 -0.20 (-0.74%)

25.93% Fall from 52W High

1.7M XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Alkermes plc is on 01 May 2025 for the purpose of Alkermes PLC First Quarter Earnings Results for 2025 See details

Alkermes plc Key Metrics

My Metrics

Select

Market Capitalization High in industry Unavailable in chosen country	4,450.6
PE TTM High in industry Unavailable in chosen country	12.1
PEG TTM High in industry Unavailable in chosen country	3.8
Price to Book Below industry Median Unavailable in chosen country	3
Institutional holding current Qtr % High in industry Unavailable in chosen country	105
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	13.9
Operating Revenue growth TTM % Negative Operating Revenue growth TTM % Unavailable in chosen country	-6.4
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	29.9
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	3.2
Operating Profit Margin Qtr % High in industry Unavailable in chosen country	37.8
Operating Profit Margin TTM % High in industry Unavailable in chosen country	27
Piotroski Score High in industry Unavailable in chosen country	7
Rel Perf vs Sector quarter% Unavailable in chosen country	-7.4
ROE Annual % High in industry Unavailable in chosen country	27.5
RoA Annual % High in industry Unavailable in chosen country	17.5

All financials are in USD Million and price data in USD

High Financial Strength

66.7 / 100

Mid Valuation

45.5 / 100

Technically Neutral

45.4 / 100

Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM

1Yr Price target upside is 47%

14 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Strong Buy Zone

18.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Alkermes plc Stock Price Analysis

Day Price Range -0.7% 1 Day return Unavailable in chosen country	27 (LTP) 2727.5 LowHigh
Month Price Range -21.4% 1 Month return Unavailable in chosen country	27 (LTP) 25.635.4 LowHigh
52 Week Price Range 13.2% 1 Year return Unavailable in chosen country	27 (LTP) 22.936.4 LowHigh

View full Share Price History

Alkermes plc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Alkermes plc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

2.2

Avg. Estimate

1.1

Low Estimate

0.9

High Estimate

1.2

Current EPS

Avg. Estimate

Miss

EPS is expected to reduce by 48.4% in FY25

Consensus Recommendation

15 ANALYST Recommendations

BUY

The consensus recommendation from 15 analysts for Alkermes plc is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Alkermes plc Stock Analysis

Alkermes plc stock analysis with key metrics, changes, and trends.

Alkermes plc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$1,557.63 M	6.36%	negative	Annual Revenue fell 6.36%, in the last year to $1,557.63 M. Its sector's average revenue growth for the last fiscal year was 7.54%.
Annual Net Profit	$367.07 M	3.18%	positive	Annual Net Profit rose 3.18% in the last year to $367.07 M. Its sector's average net profit growth for the last fiscal year was -30.36%.
Price to Earning Ratio	12.12	-	negative	Price to Earning Ratio is 12.12, higher than its sector PE ratio of 3.22.
Stock Price	$27.00	13.21%	positive	Stock Price rose 13.21% and outperformed its sector by 5.88% in the past year.
Quarterly Revenue	$429.99 M	13.91%	positive	Quarterly Revenue rose 13.91% YoY to $429.99 M. Its sector's average revenue growth YoY for the quarter was 5.84%.
Quarterly Net profit	$146.5 M	29.9%	positive	Quarterly Net profit rose 29.9% YoY to $146.5 M. Its sector's average net profit growth YoY for the quarter was -48.37%.
Debt to Equity Ratio	0.05	-	positive	Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	27.52 %	27.52%	positive	Return on Equity(ROE) for the last financial year was 27.52%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.
Mutual Fund Holding	83.91 %	0.82%	positive	Mutual Fund Holding increased by 0.82% in the last quarter to 83.91.
Promoter Share Holding	1.46 %	0.19%	positive	Promoter Share Holding increased by 0.19% in the most recent quarter to 1.46%.
Interest Coverage Ratio	20.65	-	positive	Interest Coverage Ratio is 20.65, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Institutional Holding	104.99 %	0.12%	positive	Institutional Holding increased by 0.12% in the last quarter to 104.99.

VIEW LESS

Loading data..

Alkermes plc - Company Profile

What does Alkermes plc do?

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

475.16 K

2024

Gross Remuneration

Year

Alkermes plc Live Share Price Today, Share Analysis and Chart

25.93% Fall from 52W High

Alkermes plc Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Alkermes plc Stock Price Analysis

Day Price Range

Month Price Range

52 Week Price Range

Alkermes plc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Alkermes plc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

EPS is expected to reduce by 48.4% in FY25

Consensus Recommendation

The consensus recommendation from 15 analysts for Alkermes plc is BUY

Alkermes plc Stock Analysis

Alkermes plc stock analysis with key metrics, changes, and trends.

Annual Revenue fell 6.36%, in the last year to $1,557.63 M. Its sector's average revenue growth for the last fiscal year was 7.54%.

Annual Net Profit rose 3.18% in the last year to $367.07 M. Its sector's average net profit growth for the last fiscal year was -30.36%.

Price to Earning Ratio is 12.12, higher than its sector PE ratio of 3.22.

Stock Price rose 13.21% and outperformed its sector by 5.88% in the past year.

Quarterly Revenue rose 13.91% YoY to $429.99 M. Its sector's average revenue growth YoY for the quarter was 5.84%.

Quarterly Net profit rose 29.9% YoY to $146.5 M. Its sector's average net profit growth YoY for the quarter was -48.37%.

Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was 27.52%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

Mutual Fund Holding increased by 0.82% in the last quarter to 83.91.

Promoter Share Holding increased by 0.19% in the most recent quarter to 1.46%.

Interest Coverage Ratio is 20.65, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding increased by 0.12% in the last quarter to 104.99.

Alkermes plc - Company Profile

What does Alkermes plc do?

Alkermes plc Management structure

Mr. Richard F. Pops

Chairman of the Board and Chief Executive Officer

Mr. Blair C. Jackson

Executive Vice President, Chief Operating Officer, Chief Risk Officer and Interim Principal Financial Officer

Dr. Craig C. Hopkinson, M.D.

Executive Vice President, Research and Development and Chief Medical Officer

Mr. David Joseph Gaffin

Executive Vice President, Chief Legal Officer, Secretary and Chief Compliance Officer

Mr. Christian Todd Nichols

Senior Vice President and Chief Commercial Officer

Mr. Iain M. Brown

Senior Vice President, Chief Financial Officer and Principal Accounting Officer

Alkermes plc Board of directors

Ms. Nancy S. Lurker

Independent Director